Letters archive
Join the conversation in New Scientist's Letters section, where readers can share their thoughts and opinions on articles and see responses from experts and enthusiasts across a range of science topics. To submit a letter, please see our terms and email letters@newscientist.com
2 January 2008
From Paul Branthwaite, Bench International
In her article on the high price of cancer drugs, Rachel Nowak uses emotive phrases like "inflated prices" and "most profitable industry" and "patients denied drugs" (1 December 2007, p 8) . New biological drugs are costly, largely because they are really, truly, deeply more expensive to research and manufacture than previous therapies. And other …
2 January 2008
From John Williams, Head of Science, Bishop's Stortford College
Attitudes at this school are very different to the glum picture of school science painted by Michael Reiss (1 December 2007, p 23) . Pupils enjoy science and a quarter of our 16 to 18-year-olds choose to study physics. We have our own Science Action Centre, a smaller version of the London Science Museum's Launchpad …